特定亚型的转录因子会影响乳腺癌中的聚胺代谢和瘤微环境
Qi Song1,2, Yixuan Wang1,2, Sen Liu1,2
1Cooperative Innovation Center of Industrial Fermentation (Ministry of Education and Hubei Province) Key Laboratory of Fermentation Engineering (Ministry of Education) Wuhan Hubei China.
Cancer innovation
|December 4, 2024
概括
这项研究确定了调节高风险乳腺癌中的聚胺代谢基因的关键转录因子. 这些发现为聚胺的作用和高级乳腺癌亚型的潜在治疗策略提供了新的见解.
科学领域:
- 分子生物学分子生物学
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
背景情况:
- 多氨酸对细胞生长和增殖至关重要.
- 在各种癌症中观察到聚胺代谢基因的失调.
- 控制聚胺代谢基因的转录因子及其与瘤异质性的联系仍然不完全理解.
研究的目的:
- 在乳腺癌亚型中识别失调的聚胺代谢基因及其调节转录因子.
- 研究瘤微环境和异质性在这些转录规则中的作用.
- 探索这些发现对乳腺癌治疗的临床影响.
主要方法:
- 利用大量的RNA测序数据来识别乳腺癌亚型中的失调的聚胺代谢基因和转录因子.
- 采用单细胞RNA测序 (scRNA-seq) 来分析瘤微环境中的亚型特定基因表达.
- 进行基因本体学丰富和生存分析,以了解基因功能和患者的结果.
主要成果:
- 确定了特定的聚胺代谢基因 (例如,AGMAT,CAV1,APRT,SAT1) 在乳腺癌亚型中失调,其中一些与更致命的类型有关.
- 确定了三个转录因子 (SPI1,IRF1,IRF3) 调节关键的多胺代谢基因 (SRM,APRT,SAT1).
- 在瘤微环境中证实了这些转录规则,并发现它们在高风险亚型 (例如,基底类) 中的上调调节,与化疗和辐射下较差的结果相关.
结论:
- 确定了三种特定于亚型的转录因子,这些因子调节高风险乳腺癌亚型中的聚胺代谢基因及其瘤微环境.
- 更好地了解聚胺代谢在乳腺癌进展中的作用.
- 提供了改善晚期乳腺癌亚型的临床治疗的潜在目标.
相关概念视频
The Tumor Microenvironment
6.5K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.5K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Abnormal Proliferation
4.4K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Epigenetic Regulation
3.0K
Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
X-chromosome...
3.0K
The Nucleolus
8.7K
The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K


